13.78
+0.52(+3.92%)
Currency In USD
| Previous Close | 13.26 |
| Open | 13.5 |
| Day High | 13.79 |
| Day Low | 13.2 |
| 52-Week High | 19.41 |
| 52-Week Low | 8.26 |
| Volume | 1.72M |
| Average Volume | 1.93M |
| Market Cap | 1.18B |
| PE | -8.06 |
| EPS | -1.71 |
| Moving Average 50 Days | 15.21 |
| Moving Average 200 Days | 13.09 |
| Change | 0.52 |
If you invested $1000 in Liquidia Corporation (LQDA) since IPO date, it would be worth $1,241.44 as of June 25, 2025 at a share price of $13.78. Whereas If you bought $1000 worth of Liquidia Corporation (LQDA) shares 5 years ago, it would be worth $1,204.55 as of June 25, 2025 at a share price of $13.78.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
GlobeNewswire Inc.
Jun 23, 2025 8:34 PM GMT
MORRISVILLE, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an additional $50.0
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
GlobeNewswire Inc.
Jun 02, 2025 10:30 AM GMT
YUTREPIA now available to be prescribed to patients via specialty pharmaciesFDA approved YUTREPIA on May 23, 2025Court denies United Therapeutics’ request for preliminary injunction and a temporary restraining order, clearing the path for full commer
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
MORRISVILLE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the company’s Chief Executive Officer Dr. Roger Jeffs, Chief Financial Officer and Chief Operating Officer Michael Kaseta, and Chief Busine